Edge Point Investment Group Inc. Amryt Pharma PLC Transaction History

Edge Point Investment Group Inc.

  • $11.9 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$10.9 - $14.29 $154,780 - $202,918
-14,200 Reduced 0.62%
2,277,964 $27.6 Million
Q1 2021

May 12, 2021
BUY
$13.04 - $14.75 $3.92 Million - $4.44 Million
300,905 Added 15.11%
2,292,164 $31.9 Million
Q4 2020

Feb 12, 2021
SELL
$12.22 - $14.16 $3.69 Million - $4.28 Million
-301,921 Reduced 13.17%
1,991,259 $28.2 Million
Q3 2020

Nov 13, 2020
BUY
$10.8 - $13.5 $24.8 Million - $31 Million
2,293,180 New
2,293,180 $28.3 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Edge Point Investment Group Inc. Portfolio

Follow Edge Point Investment Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Point Investment Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edge Point Investment Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email